| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/22/1992 | CA2051803A1 Aromatase inhibiting 4(5)-imidazoles |
| 03/20/1992 | WO1992004918A1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
| 03/19/1992 | WO1992004432A1 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and their esters |
| 03/19/1992 | WO1992004380A1 Specific binding agents |
| 03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| 03/19/1992 | WO1992004052A1 Modified antibodies with controlled clearance time |
| 03/19/1992 | WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | WO1992004044A1 Use of il-4 to treat solid tumors |
| 03/19/1992 | CA2091170A1 Use of il-4 to treat solid tumors |
| 03/19/1992 | CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | CA2051479A1 Heteroarylmethylbenzenes |
| 03/18/1992 | WO1992005153A1 Antiproliferative substituted naphthalene compounds |
| 03/18/1992 | EP0475623A1 Genetic mechanisms of tumor supression |
| 03/18/1992 | EP0475506A1 Pharmaceutical formulation containing a benzoyl urea derivative |
| 03/18/1992 | EP0475473A2 Novel anthracyline compounds having anti-tumour activity, novel intermediates for the preparation of these anthracycline compounds, as well as compositions containing said active anthracycline compounds |
| 03/18/1992 | EP0475230A1 Methods of conjugating actinomycin D |
| 03/18/1992 | EP0475071A1 2-acyloxy-4-morpholinyl anthracycline |
| 03/18/1992 | EP0216786B1 Purification, production and use of tumor necrosis factors |
| 03/18/1992 | CN1059519A Sulfoamide derivatives |
| 03/18/1992 | CA2091688A1 Antiproliferative substituted naphthalene compounds |
| 03/17/1992 | US5096924 Antitumor agent; isochromene derivative |
| 03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
| 03/14/1992 | WO1992005178A1 Synthetic drug molecules that mimic metalloenzymes |
| 03/14/1992 | CA2092697A1 Synthetic drug molecules that mimic metalloenzymes |
| 03/13/1992 | WO1992004362A1 2-hydroxy- and 2-acyloxy-4-morpholinyl anthracyclines |
| 03/13/1992 | CA2088979A1 2-hydroxy- and 2-acyloxy-4-morpholinyl anthracyclines |
| 03/12/1992 | DE4028139A1 Verwendung der komplexe radioaktiver metallionen mit all-cis-1,3,5-triamino-2,4,6-cyclohexantriol und seinen derivaten fuer roentgendiagnostische zwecke und in der tumortherapie sowie zur herstellung von mitteln fuer roentgendiagnostische zwecke und fuer die tumortherapie Using the complex of radioactive metal ion with all-cis-1,3,5-triamino-2,4,6-cyclohexanetriol and its derivatives for roentgendiagnostische purposes and in tumor therapy and for the manufacture of agents for roentgendiagnostische purposes and for tumor therapy |
| 03/12/1992 | CA2048094A1 Methods of conjugating actinomycin d |
| 03/11/1992 | EP0474323A1 Reducing chelants, their complexes with technetium and rhenium, method for their preparation and their use in diagnosis and therapy |
| 03/11/1992 | EP0474063A1 Dialkoxybenzylidene campher derivatives |
| 03/11/1992 | EP0473764A1 Metal complexes |
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | EP0169214B1 Anti-oestrogen drug for percutaneous administration |
| 03/11/1992 | CN1059337A Water soluble derivatives of taxol |
| 03/11/1992 | CN1059278A 抗体共轭物 Antibody conjugate |
| 03/11/1992 | CA2051034A1 Pharmaceutical formulation containing a benzoyl urea derivative |
| 03/10/1992 | US5095020 Cytostatic beta-carbolines |
| 03/10/1992 | CA1297113C (gem-heterocyclodimethanamine-n,n')platinum complexes |
| 03/10/1992 | CA1297108C Substance, composition of matter and method of using same |
| 03/10/1992 | CA1297102C Phospholipid derivatives, their production and use |
| 03/10/1992 | CA1297031C Use of avarone and avarol and derivatives thereof for the control of adult t-cell leukemia/lymphoma |
| 03/10/1992 | CA1297006C Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
| 03/08/1992 | WO1992004310A1 Triarylethylene carboxylic acids with estrogenic activity |
| 03/08/1992 | CA2089373A1 Triarylethylene carboxylic acids with estrogenic activity |
| 03/06/1992 | WO1992004056A1 USE OF RADIOACTIVE METAL ION COMPLEXES WITH all-cis-1,3,5-TRIAMINO-2,4,6-CYCLOHEXANTRIOL AND THEIR DERIVATES FOR X-RAY DIAGNOSIS AND IN TUMOR THERAPY AS WELL AS FOR PRODUCING X-RAY DIAGNOSTIC AND TUMOR THERAPY AGENTS |
| 03/06/1992 | CA2073050A1 Use of complexes of radioactive metal ions with all-cis-1,3,5-triamino-2,4, 6-cyclohexanetriol and its derivatives for radiodiagnostic purposes and in tumor therapy and for the preparation of agents for radiodiagnost c purposes and for tumor therapy |
| 03/05/1992 | WO1992004015A2 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992004014A2 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992003566A1 Therapeutic ribozyme compositions |
| 03/05/1992 | WO1992003414A1 Novel vitamin d analogues |
| 03/05/1992 | WO1992003179A1 Endocurietherapy |
| 03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
| 03/05/1992 | WO1991019707A3 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| 03/05/1992 | CA2090689A1 Regulation of t-cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090688A1 Regulation of neoplastic cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2067804A1 Endocurietherapy |
| 03/04/1992 | EP0473326A1 Water soluble derivatives of taxol |
| 03/04/1992 | EP0473268A2 Continuous release pharmaceutical compositions comprising a polypeptide covalently conjugated to a water soluble polymer |
| 03/04/1992 | EP0473080A2 Chondromodulin-I protein |
| 03/03/1992 | US5093507 Estrenes, antiglucocorticoid, antiestrogen |
| 03/03/1992 | US5093505 Pyranone and pyran-thione derivatives |
| 03/03/1992 | US5093363 2,4,6-substituted phenol derivatives |
| 03/03/1992 | US5093261 Monoclonal antibodies |
| 03/03/1992 | US5093247 Phenanthridine derivatives, process for the preparation thereof, and compositions containing them |
| 03/03/1992 | US5093115 Method of preparing activated killer monocytes for treating colorectal cancer |
| 03/03/1992 | CA1296735C Platinum(ii) complexes of 2,3-dimercapto-2-butene- dinitrilate(2-)-s,s' derivatives and process for their production |
| 03/03/1992 | CA1296667C Process for preparing lymphokine activated killer cells |
| 03/01/1992 | WO1992004455A1 Multidomain hematopoiesis stimulators |
| 03/01/1992 | WO1992004377A1 HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
| 03/01/1992 | WO1992004048A2 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 03/01/1992 | CA2090478A1 Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials |
| 03/01/1992 | CA2089375A1 Inhibition of metastatis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/26/1992 | EP0472053A2 Sulfonamide derivatives |
| 02/26/1992 | EP0472033A2 3,5-Diiod-L-thyronin for TSH-suppression and the treatment of goiter |
| 02/26/1992 | EP0471820A1 Diastereoisomeric compounds derived from tetrahydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
| 02/26/1992 | CN1058990A Protein structure of plant toxin gelonin |
| 02/25/1992 | US5091576 Antipsoriasis, insecticides |
| 02/25/1992 | US5091569 Di-tert-butyl(hydroxy)phenylthio substituted hydroxamic acid derivatives |
| 02/25/1992 | US5091531 N-imidaxo[1,2-b]pyridazinyl carbamates |
| 02/25/1992 | US5091523 Bactericides, antitumor agent |
| 02/25/1992 | US5091521 Cis-platinum complexes, a process for the preparation thereof, and pharmaceuticals containing these compounds |
| 02/25/1992 | US5091412 Novel antiviral terpene hydroquinones and methods of use |
| 02/25/1992 | US5091410 Thioxanthenone antitumor agents |
| 02/25/1992 | US5091403 Sulfinyl imidazole derivatives and antiulcer agents containing the same |
| 02/25/1992 | US5091388 Pyridobenzoindole derivatives, their preparation and compositions which contain them |
| 02/25/1992 | US5091385 Destroys tumors or other biological contaminants infecting animals |
| 02/25/1992 | US5091373 Administering sterile injectable solution of water, doxorubicin or salts and cosolubilizing agent; lyophilization |
| 02/25/1992 | US5091372 Method of treating tumors with pharmaceutical composition containing anthracycline glycosides |
| 02/25/1992 | US5091368 Biologically active compounds from blue-green algae |
| 02/25/1992 | CA1296352C Aromatic dicyclic coumpounds, process for preparing such and use thereof in cosmetics |
| 02/25/1992 | CA1296326C Anthracycline derivatives having cytostatic activity |
| 02/25/1992 | CA1296325C Nitro anthracyclines, process for their preparation and use thereof |
| 02/25/1992 | CA1296277C Salt of organogermanium compound and medicine containing the same |
| 02/24/1992 | CA2049538A1 Chondromodulin-i protein |
| 02/20/1992 | WO1992002541A1 Biologically active compounds from blue-green algae |
| 02/20/1992 | WO1992002255A1 New linker for bioactive agents |
| 02/20/1992 | WO1992002221A1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |